Preoperative transarterial chemoembolization for laparoscopic liver resection in Child A cirrhotic patients with hepatocellular carcinoma

被引:11
作者
Lopez-Lopez, Victor [1 ]
Brusadin, Roberto [1 ]
Lopez-Conesa, Asuncion [1 ]
Capel, Antonio [2 ]
Navarro-Barrios, Alvaro [1 ]
Cayuela, Valentin [1 ]
Lopez-Banet, Elena [3 ]
Garzon-Arana, Alejandro [4 ]
Parrilla-Paricio, Pascual [1 ]
Robles-Campos, Ricardo [1 ]
机构
[1] IMIB ARRIXACA, Clin & Univ Hosp Virgen de la Arrixaca, Dept Gen Visceral & Transplantat Surg, Murcia, Spain
[2] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Intervent Radiol, Murcia, Spain
[3] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Radiol, Murcia, Spain
[4] IMIB, Virgen de la Arrixaca Clin & Univ Hosp, Dept Surg Pathol, Murcia, Spain
关键词
Transarterial chemoembolization; Hepatocellular carcinoma; Laparoscopy; Liver resection; HEPATIC RESECTION; LONG-TERM; METAANALYSIS; OUTCOMES;
D O I
10.1007/s00423-020-02056-x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) offers better short-term results than open surgery with similar long-term results although it is technically difficult due to the risk of bleeding. Methods This study included patients with HCC in Child A cirrhosis who underwent TACE before LLR between 2009 and 2019. The primary endpoint was to analyze the intraoperative and early results of this technique. We also analyzed the long-term outcomes. Patients with and without clinically significant portal hypertension (CSPH) were compared. Results A total of 44 cirrhotic patients with HCC were included (24 CSPH and 20 non-CSPH). The Pringle maneuver was used in two cases (4.5%), mean blood losses was 100 ml (range 50-200), and three patients (6.8%) required a blood transfusion. The degree of necrosis achieved was greater than 90% in 27 patients (61.4%). At 1, 3, and 5 years, overall survival was 97.7%, 81.5%, and 63.4%, respectively, and disease-free survival was 85.2%, 52.5%, and 34.5%, respectively. There were no statistically significant differences between non-CSPH and CSPH groups regarding intraoperative, early, and long-term outcomes. Conclusion In our experience, TACE could be beneficial to perform LLR in HCC Child-Pugh A patients with and without CSPH without serious complications and similar oncological outcomes.
引用
收藏
页码:763 / 771
页数:9
相关论文
共 50 条
  • [21] Influence of Preoperative Transarterial Chemoembolization on the Prognosis for Patients with Resectable Hepatocellular Carcinoma: A Meta-Analysis of Randomized Trials
    Wang, Xiaofei
    Li, Jingdong
    Peng, Yong
    Dai, Yi
    Xu, Wei
    [J]. HEPATO-GASTROENTEROLOGY, 2011, 58 (107) : 869 - 874
  • [22] Laparoscopic Liver Resection for Hepatocellular Carcinoma
    Kim, Ka-Jeong
    Jeong, Chi-Young
    Jeong, Sang-Ho
    Ju, Young-Tae
    Jung, Eun-Jung
    Lee, Young-Joon
    Choi, Sang-Kyung
    Ha, Woo-Song
    Park, Soon-Tae
    Hong, Soon-Chan
    [J]. JOURNAL OF THE KOREAN SURGICAL SOCIETY, 2011, 80 (01): : 51 - 55
  • [23] Adjuvant transarterial chemoembolization for patients after curative resection of hepatocellular carcinoma: a meta-analysis
    Liao, Mingheng
    Zhu, Zexin
    Wang, Haichuan
    Huang, Jiwei
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (6-7) : 624 - 634
  • [24] Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma
    Wei, Cheng-Yi
    Chen, Po-Chun
    Chau, Gar-Yang
    Lee, Rheun-Chuan
    Chen, Ping-Hsien
    Huo, Teh-Ia
    Huang, Yi-Hsiang
    Su, Yu-Hui
    Hou, Ming-Chih
    Wu, Jaw-Ching
    Su, Chien-Wei
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (05)
  • [25] Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma
    Santambrogio, Roberto
    Bruno, Savino
    Kluger, Michael D.
    Costa, Mara
    Salceda, Juan
    Belli, Andrea
    Laurent, Alexis
    Barabino, Matteo
    Opocher, Enrico
    Azoulay, Daniel
    Cherqui, Daniel
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 (02) : 189 - 196
  • [26] Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis
    Mi, Shizheng
    Nie, Yang
    Xie, Changming
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (09) : 1070 - 1079
  • [27] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
    Chen, Xiaohong
    Zhang, Boheng
    Yin, Xin
    Ren, Zhenggang
    Qiu, Shuangjian
    Zhou, Jian
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (05) : 773 - 781
  • [28] Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection
    Xiaohong Chen
    Boheng Zhang
    Xin Yin
    Zhenggang Ren
    Shuangjian Qiu
    Jian Zhou
    [J]. Journal of Cancer Research and Clinical Oncology, 2013, 139 : 773 - 781
  • [29] Laparoscopic liver resection for hepatocellular carcinoma in cirrhotic patients: 10-year single-center experience
    Ahmed Shehta
    Ho-Seong Han
    Yoo-Seok Yoon
    Jai Young Cho
    YoungRok Choi
    [J]. Surgical Endoscopy, 2016, 30 : 638 - 648
  • [30] Hepatic resection versus transarterial chemoembolization in infiltrative hepatocellular carcinoma: A multicenter study
    Wang, Yuanqi
    Shen, Jingxian
    Feng, Shiting
    Liang, Ruiming
    Lai, Jiaming
    Li, Dongming
    Peng, Baogang
    Wang, Zaiguo
    Huang, Cheng
    Kuang, Ming
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 35 (12) : 2220 - 2228